[ET Net News Agency, 13 August 2025] SINO BIOPHARM (01177) rose 2.8% to HK$7.7.
It hits an intra-day high of HK$7.72, and an intra-day low of HK$7.41. The total shares traded was 51.37 million, with a value of HK$388.63m. The active buy/sell ratio is 69:31, with net buying turnover of HK$146.82m. CHINA INNOVATION MARKET SER accounts for greatest net responsive buying turnover of HK$7.94m, with volume weighted average price of HK$7.561. UBS accounts for greatest net responsive selling turnover of HK$21.3m, with volume weighted average price of HK$7.564. The stock has risen a combined 5.6% over the past 4 consecutive trading days.
The Hang Seng Index now rose 459 points, or 1.8% to 25,429.
Basic Information| Nominal | 7.700 | % Chg | +2.80% |
| High | 7.720 | Low | 7.410 |
| Shares Tr | 51.37m | Turnover | 388.63m |
| 10-D SMA | 7.436 | %H.V | 40.306 |
| 20-D SMA | 7.217 | VWAP | 7.565 |
| 50-D SMA | 6.071 | RSI14 | 73.532 |
Status: Active buy/sell ratio is 69:31, with net buying turnover of HK$146.82m, rising a combined 5.6% over the past 4 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| SINO BIOPHARM (01177) | 7.70 | +2.80 |
| 3SBIO (01530) | 30.74 | +0.79 |
| EVEREST MED (01952) | 70.40 | +3.68 |
| KEYMED BIO-B (02162) | 71.10 | +7.16 |
| WUXI XDC (02268) | 61.50 | +7.52 |
| ASCENTAGE-B (06855) | 80.00 | +2.17 |
| SKB BIO-B (06990) | 424.80 | +5.25 |
| ZAI LAB (09688) | 27.56 | +2.84 |
| AKESO (09926) | 158.20 | +1.09 |
| REMEGEN (09995) | 69.30 | +5.16 |
(ed)
